OMCL

Insider Trades

Name	Value	Action	Price	Current Price
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICER $217k5k shares SellMay 18, 2026 $43.22 --
Njoku NnamdiEVP, Chief Operating Officer $134k3.1k shares SellMay 18, 2026 $43.22 --
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICER $257k7.4k shares SellMar 16, 2026 $34.69 --
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICER $155k4.2k shares SellFeb 17, 2026 $36.59 --
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICER $305k6.1k shares SellJan 8, 2026 $49.90 --
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICER $12k278 shares SellDec 16, 2025 $43.30 --

News

zacks.comOMCL vs. HIMS: Which Stock Is the Better Value Option?zacks.comJun 10

zacks.comOmnicell (OMCL) is a Top-Ranked Value Stock: Should You Buy?zacks.comJun 10

seekingalpha.comOmnicell, Inc. (OMCL) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.comJun 9

seekingalpha.comOmnicell: Why I'm Long Into Q2 Earnings Despite The Bookings Wobbleseekingalpha.comJun 9

businesswire.comOmnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Businessbusinesswire.comJun 8

Trade OMCL

About Omnicell, Inc.

Omnicell, Inc., founded in 1992 and headquartered in Mountain View, California (initially operating as Omnicell Technologies, Inc. until its name change in 2001), delivers advanced medication management technologies and patient adherence solutions. The company serves healthcare systems and pharmacies both domestically within the United States and globally. Its extensive portfolio of offerings includes: Clinical Workflow Automation: Omnicell provides automated solutions designed to streamline clinician tasks in patient care environments. This encompasses the XT Series automated dispensing units for medications and supplies across nursing units, clinical areas, and surgical suites. They also offer interface software to ensure smooth integration between their products and a healthcare facility's existing information systems, alongside robotic systems for automated storage and retrieval of packaged medications. Central Pharmacy Optimization: For the central pharmacy, Omnicell offers sophisticated automation, including automated storage and retrieval platforms like the XR2 Automated Central Pharmacy System. This segment also features robotic systems and workflow management tools for IV compounding, comprehensive inventory management software, and systems for controlled substance oversight. Single-Dose Packaging for Adherence: The company develops automated technologies for filling and labeling patient-specific, single-dose medication blister packaging according to prescriptions. This includes both fully and semi-automated equipment for institutional pharmacies to ensure precise packaging, along with blister card packaging and supplies aimed at improving medication adherence, particularly in non-acute care settings. Digital Patient Engagement: Omnicell further provides EnlivenHealth Patient Engagement, a web-based platform offering various tools to interact with patients.

CEO: Randall A. Lipps
IPO Date: Aug 9, 2001

Market Data

Open: $38.97
High: $39.41
Low: $37.63
Volume: 1.2M
Avg Volume: 581.4K
52W High: $55.00
52W Low: $26.85

Valuation

Market Cap: $1.8B
Enterprise Value: $1.7B
Dividend Yield: 0.00%

Financials

Free Cash Flow: $87M
Revenue: $1.2B
Net Income: $2.1M
Cash: $197M
Debt: $204M

Events

EarningsJul 30

EPS est. 0.48